JSR acquisition creates potential business disposal opportunities

Mitsui has indicated that it plans to sell JSR's life sciences business and other non-core assets as part of its wider restructuring. HPC could identify potential buyers, investment firms and strategic partners for these businesses. This is a potential future mandate rather than an announced sale process, so buyer interest and the disposal timetable would need to be verified. [Reuters]

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.